Kura Oncology, Inc. 4
4 · Kura Oncology, Inc. · Filed Jan 25, 2017
Insider Transaction Report
Form 4
LIU YI
Chief Scientific Officer
Transactions
- Award
Option to purchase common stock
2017-01-23+63,000→ 63,000 totalExercise: $6.15Exp: 2027-01-22→ Common Stock (63,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments commencing on the grant date.